Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study

Sponsor
University Hospital Birmingham NHS Foundation Trust (Other)
Overall Status
Completed
CT.gov ID
NCT04440124
Collaborator
(none)
121
1
26
4.7

Study Details

Study Description

Brief Summary

The purpose of this study was to assess the predictive value of the incremental shuttle walk test on rates of hospital acquired pneumonia for patients undergoing oesophagectomy.

Condition or Disease Intervention/Treatment Phase
  • Other: Incremental shuttle walk test

Detailed Description

Field tests to objectively measure functional capacity are becoming of greater importance when looking to assess an individual's fitness for surgery. One such field test is the incremental shuttle walk test (ISWT). An externally paced, maximal excursion test, the ISWT is a simple and easily reproducible test that is widely used within cardiac and pulmonary populations and shown to correlate well with Vo2 mas on a cardiopulmonary exercise test. Previous studies looking at the benefit of the ISWT in predicting post-operative outcomes within the oesophagastric population have demonstrated that walking less than 350 meters has been associated with significantly higher rates of mortality at 30 days and 3 years. No correlation between ISWT and postoperative respiratory complications in this surgical population has been previously reported.

This study aims to assess whether walking <350 meters on an ISWT predicts the development of hospital acquired pneumonias following an elective oesophagectomy

Study Design

Study Type:
Observational
Actual Enrollment :
121 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Does the Incremental Shuttle Walk Test Predict the Development of a Hospital Acquired Pneumonia in Patients Undergoing Elective Oesophagectomy: A Prospective Cohort Study
Actual Study Start Date :
Dec 1, 2017
Actual Primary Completion Date :
Feb 1, 2020
Actual Study Completion Date :
Feb 1, 2020

Outcome Measures

Primary Outcome Measures

  1. Hospital acquired pneumonia [during hospital stay, on average 14 days]

    The incidence of hospital acquired pneumonia as defined by the US centres for Disease Control

Secondary Outcome Measures

  1. 30 day Mortality [30 days after date of surgery]

    Mortality rates 30 days post operatively

  2. 90 day Mortality [90 days following date of surgery]

    Mortality rates 90 days post operatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Consecutive patients with a diagnosis of oesophagogastric cancer listed for an elective oesophagectomy at a large UK tertiary hospital
Exclusion Criteria:
  • Patients who were unable to complete the walking test

  • patients deemed not fit for surgery

  • patients with a significant neurological event peri or post operatively

Contacts and Locations

Locations

Site City State Country Postal Code
1 UHB NHS Foundation Trust Birmingham United Kingdom B15 2GW

Sponsors and Collaborators

  • University Hospital Birmingham NHS Foundation Trust

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David McWilliams, Consultant Physiotherapist, University Hospital Birmingham NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT04440124
Other Study ID Numbers:
  • JW01
First Posted:
Jun 19, 2020
Last Update Posted:
Jun 19, 2020
Last Verified:
Jun 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by David McWilliams, Consultant Physiotherapist, University Hospital Birmingham NHS Foundation Trust
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 19, 2020